Notably, late-stage colon cancer patients had lower expressions of DECTIN-3 and conversely DECTIN-3 expression was high in patients with low fungal burden and high fungal burden predicted worse progression-free survival and overall survival. Here, CLEC4D is linked to malignant colon neoplasm.